NASDAQ : ACB
Aurora Cannabis Inc. — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Canada
Last price 4.06 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 266.70M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 266.70M |
| Enterprise Value | 211.26M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 65.74M |
| Shares Outstanding | 64.86M |
| Shares Change (YoY) | +3.77% |
| Shares Change (QoQ) | +7.49% |
| Owned by Insiders (%) | 0.61% |
| Owned by Institutions (%) | 8.24% |
| Float | 65.35M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.21 |
| Forward PS | 1.22 |
| PB Ratio | 0.72 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.36 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -24.32 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -9.40% |
| Return on Assets (ROA) | -3.72% |
| Return on Invested Capital (ROIC) | -10.01% |
| Return on Capital Employed (ROCE) | -7.94% |
| Weighted Average Cost of Capital (WACC) | 11.75% |
| Revenue Per Employee | $215,137 |
| Profits Per Employee | -$82,290 |
| Employee Count | 1,028 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 0.84 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.81M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -17.98% |
| 50-Day Moving Average | 4.05 |
| 200-Day Moving Average | 3.54 |
| Relative Strength Index (RSI) | 50.19 |
| Average Volume (20 Days) | 1,061,675 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 8.20M |
| Short Previous Month | 7.64M |
| Short % of Shares Out | 12.64% |
| Short % of Float | 12.54% |
| Short Ratio (days to cover) | 7.49 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 221.16M |
| Gross Profit | 97.70M |
| Operating Income | -30.60M |
| Pretax Income | -35.14M |
| Net Income | -84.59M |
| EBITDA | -21.09M |
| EBIT | -30.60M |
| Loss Per Share | -$1.48 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 70.44M |
| Total Debt | 15.97M |
| Net Cash | 54.46M |
| Net Cash Per Share | $0.84 |
| Equity (Book Value) | 371.19M |
| Book Value Per Share | 5.86 |
| Working Capital | 225.35M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -20.09M |
| Capital Expenditures | -16.52M |
| Depreciation & Amortization | 9.66M |
| Net Borrowing | -3.62M |
| Free Cash Flow | -36.61M |
| FCF Per Share | -$0.56 |
Margins
| Measure | Value |
|---|
| Gross Margin | 44.18% |
| Operating Margin | -13.83% |
| Pretax Margin | -15.89% |
| Profit Margin | -38.25% |
| EBITDA Margin | -9.54% |
| EBIT Margin | -13.83% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -3.77% |
| Shareholder Yield | -3.77% |
| Earnings Yield | -36.48% |
| FCF Yield | -13.73% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.29 |
| Price Target Difference | 5.67% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 3.40% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 20, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -11.5 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |